Oral Fluid Testing Could Detect Sativex Use and Distinguish It From Smoked Cannabis
Oral fluid cannabinoid testing could distinguish between oral THC medication, Sativex spray, and smoked cannabis based on CBD/THC ratios and THCCOOH/THC ratios, enabling compliance monitoring and relapse detection.
Quick Facts
What This Study Found
Fourteen participants received oral THC (5 and 15 mg), low-dose Sativex, high-dose Sativex, and placebo in random order. After oral THC, oral fluid THC concentrations actually decreased over time (reflecting clearance of residual THC from prior smoked cannabis), with no measurable CBD or CBN.
After Sativex spray, THC, CBD, and CBN all increased dramatically, peaking within 15-60 minutes. The CBD/THC ratio was 0.82-1.34, reflecting Sativex's composition. THCCOOH/THC ratios within 4.5 hours post-Sativex were consistently below 1.6 pg/ng, always lower than after oral THC or placebo. These distinct patterns could identify Sativex compliance and distinguish it from smoked cannabis.
Key Numbers
14 participants. After Sativex: CBD/THC ratio 0.82-1.34. CBN/THC ratio 0.04-0.06. THCCOOH/THC <1.6 pg/ng within 4.5 hours. After oral THC: THC decreased over time, no CBD or CBN detected.
How They Did This
Randomized, placebo-controlled crossover study. 14 participants received 5 mg oral THC, 15 mg oral THC, low-dose Sativex (5.4 mg THC + 5.0 mg CBD), high-dose Sativex (16.2 mg THC + 15.0 mg CBD), and placebo. Oral fluid collected for 10.5 hours. Analyzed for THC, CBD, CBN, THCCOOH.
Why This Research Matters
As medical cannabinoids become more common, the ability to monitor medication compliance and detect unauthorized cannabis use becomes important. This study established that oral fluid testing can distinguish between different cannabinoid products based on their unique metabolite patterns.
The Bigger Picture
This research addressed a practical clinical and forensic need: how to distinguish between legal medical cannabinoid use and illicit cannabis smoking. The pharmacokinetic profiles are sufficiently different to allow differentiation, supporting the development of monitoring protocols.
What This Study Doesn't Tell Us
Small sample (14 participants). Oral fluid collection variability could affect results. The study participants had prior cannabis exposure, complicating baseline measurements. Real-world testing scenarios involve more variables than a controlled laboratory setting. The time window for detection varies.
Questions This Raises
- ?Could these markers be used in workplace drug testing to distinguish medical from recreational cannabis?
- ?How long after Sativex administration can compliance be confirmed?
- ?Would these patterns hold in chronic medical cannabis users?
Trust & Context
- Key Stat:
- CBD/THC ratio of 0.82-1.34 in oral fluid specifically identified Sativex use
- Evidence Grade:
- Controlled crossover study with precise pharmacokinetic measurements; moderate evidence for clinical monitoring utility.
- Study Age:
- Published in 2013. Oral fluid cannabinoid testing has continued to develop for both clinical and forensic applications.
- Original Title:
- Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
- Published In:
- Drug and alcohol dependence, 130(1-3), 68-76 (2013)
- Authors:
- Lee, Dayong(6), Karschner, Erin L(4), Milman, Garry(3), Barnes, Allan J, Goodwin, Robert S, Huestis, Marilyn A
- Database ID:
- RTHC-00695
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Can a drug test tell the difference between medical cannabis and smoked marijuana?
Yes, according to this study. Sativex (a medical THC/CBD spray) produces a distinctive pattern in oral fluid: high CBD/THC ratios (reflecting the equal CBD and THC content) and low THCCOOH/THC ratios shortly after use. Smoked cannabis and oral THC produce different patterns. However, this type of detailed analysis is not typically performed in standard workplace drug testing.
Can oral fluid detect if a patient is taking their cannabis medication as prescribed?
This study showed that Sativex produces measurable spikes in THC, CBD, and CBN in oral fluid within minutes of use, providing a way to confirm compliance. However, the window for detection is limited, and oral fluid is more useful for detecting recent use than for long-term compliance monitoring.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-00695APA
Lee, Dayong; Karschner, Erin L; Milman, Garry; Barnes, Allan J; Goodwin, Robert S; Huestis, Marilyn A. (2013). Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?. Drug and alcohol dependence, 130(1-3), 68-76. https://doi.org/10.1016/j.drugalcdep.2012.10.011
MLA
Lee, Dayong, et al. "Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?." Drug and alcohol dependence, 2013. https://doi.org/10.1016/j.drugalcdep.2012.10.011
RethinkTHC
RethinkTHC Research Database. "Can oral fluid cannabinoid testing monitor medication compli..." RTHC-00695. Retrieved from https://rethinkthc.com/research/lee-2013-can-oral-fluid-cannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.